SWOG clinical trial number
SWOG-9116

Evaluation of Piroxantrone in Disseminated Malignant Melanoma, Phase II

Closed
Phase
Accrual
100%
Published
Abbreviated Title
Evaluation of Piroxantrone in Disseminated Malignant Melanoma, Phase II
Activated
06/01/1992
Closed
10/01/1993

Publication Information Expand/Collapse

2008

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. [PMID18235113]

EL Korn;PY Liu;SJ Lee;JAW Chapman;D Niedzwiecki;VJ Suman;J Moon;VK Sondak;MB Atkins;EA Eisenhauer;W Parulekar;SN Markovic;S Saxman;JM Kirkwood Journal of Clinical Oncology 26(4):527-534

2001

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials

JM Unger;LE Flaherty;PY Liu;KS Albain;VK Sondak Cancer 91(6):148-1155

1995

Phase II trial of piroxantrone in disseminated malignant melanoma: A Southwest Oncology Group study.

J Sosman;PY Liu;A Hantel;L Flaherty;V Sondak ASCO 14:418(#1330)

A phase II trial of piroxantrone in disseminated malignant melanoma: A Southwest Oncology Group study.

JA Sosman;LE Flaherty;PY Liu;W Fletcher;JA Thompson;A Hantel;V Sondak Investigational New Drugs 13:83-87